Skip to main content

Year: 2021

Aehr Test Systems to Participate at Craig-Hallum Alpha Select Virtual Conference on November 16, 2021

FREMONT, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will participate at the Craig-Hallum 12th Annual Alpha Select Virtual Conference on Tuesday, November 16, 2021. Aehr Test President and CEO Gayn Erickson and CFO Ken Spink will be hosting virtual meetings with investors throughout the day. “We look forward to discussing our semiconductor wafer level and singulated die test and burn-in solutions and the markets they serve with investors,” said Mr. Erickson. “Aehr Test provides complete production solutions for improving yield and reliability of semiconductors, and devices such as silicon carbide semiconductors used in electric and hybrid electric vehicles, silicon photonics devices used in...

Continue reading

Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

CAPLYTA supplemental new drug applications (sNDAs) for the treatment of bipolar depression are under review by the FDA, with a PDUFA target action date of December 17, 2021. Bipolar depression launch preparations are progressing well; sales force expansion is substantially complete. Total revenues were $22.2 million for the third quarter of 2021, compared to $7.4 million for the same period in the prior year, representing an increase of approximately 200%. CAPLYTA achieved net product revenues of $21.6 million for the third quarter of 2021. Third quarter CAPLYTA total prescriptions (TRx) increased 15% versus the previous quarter. Patient enrollment is ongoing in a pivotal program evaluating lumateperone as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD).NEW YORK, Nov. 09, 2021 (GLOBE...

Continue reading

Olema Oncology to Present at Two Upcoming Investor Conferences

SAN FRANCISCO, Nov. 09, 2021 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that management will participate in two upcoming investor conferences in November. Details for the company’s participation are as follows:Event: Jefferies London Healthcare ConferenceDate: Tuesday, November 16, 2021Time: 5:00 p.m. GMT (12:00 p.m. ET / 9:00 a.m. PT)Format: Live Fireside Chat Event: 4th Annual Evercore ISI HealthCONx ConferenceDate: Tuesday, November 30, 2021Time: 11:45 a.m. ET (8:45 a.m. PT) Format: Live Fireside ChatLive webcasts of these presentations may be accessed under the Investors & Media section of Olema’s website (www.olema.com)...

Continue reading

TG Therapeutics to Participate in the B. Riley Securities Fall 2021 Growth Biotech Best Ideas Virtual Series

Fireside chat scheduled for 12:00 PM ET on Thursday November 11, 2021 NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the B. Riley Securities’ Fall 2021 Growth Biotech Best Ideas Virtual Series, taking place on Thursday November 11, 2021, at 12:00 PM ET. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events. A replay of the webcast will be available on TG’s website following the event. ABOUT TG THERAPEUTICS, INC.TG Therapeutics is a fully-integrated, commercial stage biopharmaceutical company focused on the acquisition, development...

Continue reading

Acerus Reports Fiscal Third Quarter Financial Results

TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2021. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”). Third Quarter Highlights31% year-over-year quarterly growth of NATESTO® total prescriptions (“TRx”) in the U.S. market Settlement of litigation against Recipharm Limited, the Company’s former contract manufacturer for ESTRACE®, reflected as $2.3 million in other income as well as $0.4 million of reimbursed litigation expenses New Orange Book listed patent for NATESTO® extends intellectual property protection in the United States to 2034“The third quarter was...

Continue reading

President & CEO of Nova Leap Health Corp. to Present at the Q4 Virtual Investor Summit

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 09, 2021 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the Q4 Virtual Investor Summit event to be held November 16-17, 2021. About the Q4 Virtual Summer Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q4 Investor Summit will take place virtually, featuring 90+ companies and over 300 institutional and retail investors. Mr. Chris Dobbin, President & CEO of Nova Leap, will be presenting at the event by way of webcast on Tuesday, November...

Continue reading

Whole Earth Brands, Inc. Reports Third Quarter 2021 Financial Results and Reiterates Full Year Guidance

Reported Third Quarter Consolidated Revenue Growth of 92.4%, Including Strategic Acquisitions Third Quarter Organic Constant Currency Revenue Growth of 6.1% Including Acquisitions in Both Periods Third Quarter Branded CPG Proforma Organic Constant Currency Revenue Growth of 7.6% vs 2020 and 14.3% on a Two-year Stacked Basis (versus Third Quarter 2019) Largely Due to Strong Volume Third Quarter Operating Income of $13.5 Million and Record Adjusted EBITDA of $22.1 Million CHICAGO, Nov. 09, 2021 (GLOBE NEWSWIRE) — Whole Earth Brands, Inc. (the “Company” or “we” or “our”) (Nasdaq: FREE), a global food company enabling healthier lifestyles by providing access to premium plant-based sweeteners, flavor enhancers and other foods through a diverse portfolio of trusted brands and delicious products, today announced its financial results...

Continue reading

Neuronetics Reports Third Quarter 2021 Financial and Operating Results

MALVERN, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced its financial and operating results for the third quarter of 2021. Third Quarter 2021 HighlightsAs previously announced, third quarter 2021 revenue of $13.8 million, an increase of 11% over third quarter 2020Entered into an agreement with Zion Healing, in which the Company will be the exclusive supplier of TMS equipment to Zion Healing and its franchiseesIn September, entered into a five-year contract extension with Success TMS, in which the Company will be the exclusive supplier of TMS equipment to Success TMSProvided a $10 million strategic...

Continue reading

LimitFi & SiriusPoint Announce Multi-Year Underwriting Partnership and Strategic Investment

Partnership further enhances LimitFi’s platform providing credit insurance and reinsurance solutions NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) — Limit Financial (LimitFi), a managing general agent (MGA) specializing in credit insurance and reinsurance solutions, and SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, today announced a multi-year underwriting capacity partnership and a strategic investment that will support existing and future credit insurance product offerings. This partnership provides LimitFi with committed capacity to execute credit insurance, and SiriusPoint with immediate access to credit insurance opportunities underwritten through LimitFi’s platform. LimitFi will provide an end-to-end solution including the origination, analysis, and management of all policies. “LimitFi...

Continue reading

Life Clips Subsidiary Belfrics Group Plans Major Expansion In India

Belfrics Group announces plans to expand its technology team and open 200 independently owned physical crypto centers in the next 6 months to meet the demands of the fast-growing Indian cryptocurrency market AVENTURA, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) announced today its wholly owned subsidiary Belfrics Group, one of India’s early adopters of blockchain and cryptocurrency, plans to expand its technology team and open 200 independently owned physical crypto centers in the next 6 months to meet the demands of the fast-growing Indian cryptocurrency market. Belfrics expects to initially open more than 20 independently owned Belfrics Phygital Centers to sell its exchange and blockchain products. Each office will be independently owned by highly qualified and well-respected local...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.